We kept our promise

We are back with the 2 nd issue of Onconeph
#Onconephrology
12 🔥 articles
40+ authors
Great collaborative effort

@kdjhaveri
@MegSise
@CharuThakar
@ackdonline
@NKF_NephPros
@nkf
@onconephsociety
@UCKidney
@uofcincy
@UCincyMedicine
@ucincipress 🔥Our editorial speaks about the summary of the individual topics.
Paraproteinemia
TMA $
Na/K ⬇️⬆️in Ca
Palliative Rx
HSCT & kidney
Heme cancer & kidney
Paraneoplastic GN
Sickle cell ds
OncoSx and AKI
Anemia & cancer
Anti Ca Rx dosing in CKD
TxP Onconeph

Hot out of press.
"AKI in critically ill patients with cancer"

@ShrutiGkidney @BWHKidney @MGHKidneys @DanaFarber
@kdjhaveri @HofstraKidney
@CJASN
@onconephsociety
@UCincyMedicine @UCKidney @UCincyIM
#Onconephrology

Causes of AKI in pts with cancer in nutshell ⬇️ ⭐️Phenotypes of AKI from monoclonal gammopathy
⭐️ Data suggest that patients with MGRS are at high risk for progression to kidney failure if not treated with clone-directed therapy (e.g., bortezomib)

Read more about it in the section "Monoclonal Gammopathies and AKI" ⬇️